Thoracic neuroendocrine tumors;Tumeurs neuroendocrines thoraciques

Annales de Pathologie

Volumn 25, Issue 6, 2005, Pages 529-544

  Brambilla, Elisabeth ^a,b   Lantuejoul, Sylvie ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b HÔPITAL MICHALLON   (France)

Author keywords

Carcinoids; Large cell neuroendocrine carcinoma; Lung; Neuroendocrine tumors; Small cell carcinoma; Thymus

Indexed keywords

BRONCHUS CARCINOID; CANCER CLASSIFICATION; CANCER GRADING; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; LARGE CELL CARCINOMA; LUNG SMALL CELL CANCER; NEUROENDOCRINE TUMOR; PROGNOSIS; REVIEW; SMALL CELL CARCINOMA; THYMUS CANCER; TISSUE SECTION;

EID: 33646383106     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0242-6498(05)86165-6     Document Type: Short Survey

References (74)

1. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. WHO Histological Classification of Tumours. Histological Typing of Lung and Pleural Tumours. 3rd ed. Springer-Verlag : Berlin. 1999.
2. Travis WD, Brambilla E, Muller-Hemerlink HK, Harris CC. Eds : World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press : Lyon 2004.
3. Curran WJ Jr. Therapy of limited stage small cell lung cancer. Cancer Treat Res 2001 ; 105 : 229-52.
4. Brambilla E, Jacrot M, Batandier C, Brichon PY, Morel F, Nagy-Mignotte H et al. Heterotransplantation of small cell lung carcinoma into Nude mice : stability of phenotypic characters. Cancer 1989 ; 64 : 42-71.
5. Sturm N, Rossi G, Lantuejoul S, Laverrière MH, Papotti M, Brichon PY et al. 34βE12 expression along the whole spectrum of neuroendocrine proliferations of the lung, from neuroendocrine cell hyperplasia to small cell carcinoma. Histopathology 2003 ; 42 : 156-66.
6. Fletcher JA. Role of KIT and Platelet-derived growth factor receptors as oncoproteins. Semin Oncol 2004 ; 31 : 4-11.
7. Hibi K, Takahashi T, Sekido Y et al. Coexpression of stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 1991 ; 6 : 2291-6.
8. Rygaard K, Nakamura T, Spang-Thomsen M. Expression of the protooncogene c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor in SCLC cell lines and xenografts. Br J Cancer 1993 ; 67 : 137-46.
9. Dy GK, Adjei AA. Novel targets for lung cancer therapy : part I. J Clin Oncol 2002 ; 20 : 2881-94.
10. Sattler M, Salgia R. Molecular and cellular biology of small cell lung cancer. Semin Oncol 2003 ; 30 : 57-71.
11. Halliday BE, Slagel DD, Elsheikh TE, Silverman JF. Diagnostic utility of MIC-2 immunocytochemical staining in the differential diagnosis of small blue cell tumors. Diagn Cytopathol 1998 ; 19 : 410-6.
12. Lumadue JA, Askin FB, Perlman EJ. MIC2 analysis of small cell carcinoma. Am J Clin Pathol 1994 ; 102 : 692-4.
13. Osterlind K, Andersen PK. Prognostic factors in small cell lung cancer : multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 1986 ; 46 : 4189-94.
14. Souhami RL, Bradbury I, Geddes DM, Spiro SG, Harper PG, Tobias JS. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung. Cancer Res 1985 ; 45 : 2878-82.
15. Arrigoni MG, Woolner LB, Bernatz PE. Atypical carcinoid tumors of the lung. J Thoracic Cardiovasc Surg 1972 ; 44 : 413-21.
16. Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA, Koss MN. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998 ; 22 : 934-44.
17. Harpole DH Jr, Feldman JM, Buchanan S, Young WG, Wolfe WG. Bronchial carcinoid tumors : a retrospective analysis of 126 patients. Ann Thorac Surg 1992 ; 54 : 50-5.
18. Quaedvlieg PFHJ, Visser O, Lamers CBHW, Janssen-Heijen MLG, Taal BG. Epidemiology and survival in patients with carcinoid disease in the Netherlands. An epidemiological study with 2391 patients. Ann Oncol 2001 ; 12 : 1295-300.
19. Skuladottir H, Hirsch FR, Hansen HH, Olsen JH. Pulmonary neuroendocrine tumors : incidence and prognosis of histological subtypes. A population-based study in Denmark. Lung Cancer 2002 ; 37 : 127-35.
20. Beasley MB, Thunnissen FBJM, Brambilla E, Hasleton P, Steele R, Hammar SP et al. Pulmonary atypical carcinoid : predictors of survival in 106 cases. Human Pathol 2000 ; 31 : 1255-65.
21. McCaughan BC, Martini N, Bains MS. Bronchial carcinoids. Review of 124 cases. J Thorac Cardiovasc Surg 1985 ; 89 : 8-17.
22. Debelenko L, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 1997 ; 13 : 2285-90.
23. Brambilla E, Brambilla C. Hétérogénéité des cancers bronchiques. Problèmes d'histogénèse. Rev Mal Resp 1986 ; 5 : 235-45.
24. Lantuejoul S, Moro D, Michalides RJ, Brambilla C, Brambilla E. NCAM and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol 1998 ; 22 : 1267-76.
25. Bergh J, Esscher T, Steinholtz L, Nilsson K, Phalman S. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers. Am J Clin Pathol 1985 ; 84 : 1-7.
26. Linnoila RI, Mushine JL, Steinberg et al. Neuroendocrine differentiation in endocrine and non endocrine lung carcinoma. Am J Clin Pathol 1988 ; 90 : 641-52.
27. Sturm N, Rossi G, Lantuejoul S, Papotti M, Frachon S, Claraz C et al. Expression of thyroid transcription factor-1 (TTF-1) in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Human Pathol 2002 ; 33 : 175-82.
28. Folpe AL, Gown AM, Lamps LW, Garcia R, Dail DH, Zarbo RJ et al. Thyroid transcription factor-1 : immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 1999 ; 12 : 5-8.
29. Oliveira AM, Tazelaar HD, Myers JL, Erickson LA, Lloyd RV. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 2001 ; 25 : 815-9.
30. Du EZ, Goldstraw P, Zacharias J, Tiffet O, Craig PJ, Nicholson AG et al. TTF-1 expression is specific for lung primary in typical and atypical carcinoids : TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 2004 ; 35 : 825-31.
31. Jones MH, Virtanen C, Honjoh D, Miyoshie T, Satoh Y, Okumura S et al. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles. Lancet 2004 ; 363 : 775-81.
32. Costes V, Marty-Ane C, Picot MC, Serre I, Pujol JL, Mary H, Baldet P. Typical and atypical bronchopulmonary carcinoid tumors : a clinicopathologic and KI-67-labeling study. Hum Pathol 1995 ; 26 : 740-5.
33. Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, Koss MN, Travis WD. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies : TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol 2000 ; 24 : 906-16.
34. Travis MD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB Jr, Nieman L et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991 ; 15 : 529-53.
35. Demirer T, Ravits J, Aboulafia D. Myasthenic (Eaton-Lambert) syndrome associated with pulmonary large-cell neuroendocrine carcinoma. South Med J 1994 ; 87 : 1186-9.
36. Brambilla E, Veale D, Moro D, Morel F, Dubois F, Brambilla C. Neuro-endocrine phenotype in lung cancers : comparison of immunochemistry with biochemical determination od enolase isoenzymes. Am J Clin Pathol 1992 ; 98 : 88-97.
37. Lyda MH, Weiss LM. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. Hum Pathol 2000 ; 31 : 980-7.
38. Sturm N, Lantuejoul S, Laverriere MH, Papotti M, Brichon PY, Brambilla C et al. Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. Hum Pathol 2001 ; 32 : 918-25.
39. Wick MR, Berg LC, Hertz MI. Large cell carcinoma of the lung with neuroendocrine differentiation. A comparison with large cell "undifferentiated" pulmonary tumors. Am J Clin Pathol 1992 ; 97 : 796-805.
40. Dresler CM, Ritter JH, Patterson AG et al. Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg 1997 ; 63 : 180-5.
41. Jiang SX, Kameya T, Shoji M et al. Large cell neuroendocrine carcinoma of the lung. A histologic and immunohistochemical study of 22 cases. Am J Surg Pathol 1998 ; 22 : 526-37.
42. Jung KJ, Lee KS, Han J et al. Large cell neuroendocrine carcinoma of the lung : clinical, CT, and pathologic findings in 11 patients. J Thorac Imaging 2001 ; 16 : 156-62.
43. Takei H, Asamura H, Maeshima A et al. Large cell neuroendocrine carcinoma of the lung : a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 2002 ; 124 : 285-92.
44. Mazieres J, Daste G, Molinier L et al. Large cell neuroendocrine carcinoma of the lung : pathological study and clinical outcome of 18 resected cases. Lung Cancer 2002 ; 37 : 287-92.
45. Iyoda A, Hiroshima K, Baba M et al. Pulmonary large cell carcinomas with neuroendocrine features are high-grade neuroendocrine tumors. Ann Thorac Surg 2002 ; 73 : 1049-54.
46. Hage R, Seldenrijk K, de Bruin P et al. Pulmonary large-cell neuroendocrine carcinoma (LCNEC). Eur J Cardiothorac Surg 2003 ; 23 : 457-60.
47. Paci M, Cavazza A, Annessi V et al. Large cell neuroendocrine carcinoma of the lung : a 10-year clinicopathologic retrospective study. Ann Thorac Surg 2004 ; 77 : 1163-7.
48. Zacharias J, Nicholson AG, Ladas GP et al. Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung : prognosis after complete resection and systematic nodal dissection. Ann Thorac Surg 2003 ; 75 : 348-52.
49. Doddoli C, Barlesi F, Chetaille B et al. Large cell neuroendocrine carcinoma of the lung : an aggressive disease potentially treatable with surgery. Ann Thorac Surg 2004; 77: 1168-72.
50. Cerilli LA, Ritter JH, Mills SE et al. Neuroendocrine neoplasms of the lung. Am J Clin Pathol 2001 ; 116 : S65-S96.
51. Rossi G, Cavazza A, Marchioni A et al. Kit expression in small cell carcinomas of the lung : effects of chemotherapy. Mod Pathol 2003 ; 16 : 1041-7.
52. Casali C, Stefani A, Rossi G et al. The prognostic role of c-kit expression in resected large cell neuroendocrine carcinomas of the lung. Ann Thorac Surg 2004 ; 77 : 247-53.
53. Rossi G, Cavazza A, Marchioni A, Longo L, Migaldi M, Sartori G et al. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRα, PDG-FRβ and Met in large cell neuroendocrine carcinoma of the lung. J Clin Oncol 2005 ; 23 : 8774-85.
54. Shimosato Y, Mukai K. Tumors of the mediastinum, in Rosai J (ed), Atlas of Tumor Pathology, Series 3, fascicle 21, Washington, DC, Armed Forced Institute of Pathology, 1997, pp 333- 373.
55. Mizumo T, Masaoka A, Hashimoto et al. Coexisting thymic carcinoid tumor and thymoma. Ann Thorac Surg 1990 ; 50 : 650-2.
56. Klemm KM, Moran CA. Primary neuroendocrine carcinomas of the thymus. Sem Diag Pathol 1999 ; 16 : 32-41.
57. Wick MR, Scott RE, Li YC, Carney JA. Carcinoid tumor of the thymus : a clinicopathologic report of seven cases with a review of the literature. Mayo Clinic Proc 1980 ; 55 : 246-54.
58. Ritter JH, Wick MR. Primary carcinomas of the thymus gland. Sem Diag Pathol 1999 ; 16 : 18-31.
59. Wick MR, Ritter JH. Neuroendocrine neoplasms : evolving concepts and terminology. Curr Diag Pathol 2002, 8 : 102- 112,
60. OMS 2004 pp 188-195.
61. Rosai J, Levine G, Weber R, Higa E. Carcinoid tumors and oat cell carcinomas of the thymus. Pathol Annu 1977 ; 2 : 33-62.
62. Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid tumors) of the thymus : a clinicopathologic analysis of 80 cases, Cancer 1999,
63. Klemm KM, Moran CA. Primary neuroendocrine carcinomas of the thymus. Sem Diag Pathol 1999 ; 16 : 32-41.
64. Moran CA, Suster S. Primary neuroendocrine carcinoma (thymic carcinoid) of the thymus with prominent oncocytic features : a clinicopathologic study of 22 cases. Mod Pathol 2000 ; 13 : 489-94.
65. Shimosato Y, and Mukai K. Atlas of tumor pathology : Tumors of hte mediastinum. 3rd series, fascicule 21. Washington, DC : Armed Forces Institute of Pathology, 1997 : 158-82.
66. Valli M, Fabris GA, Dewar A, Chikte S, Fisher C, Corrin B et al. Atypical carcinoid tumour of the thymus : a study of eight cases. Histopathology 1994 ; 24 : 371-5.
67. Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol 2000 ; 114 : 100-10.
68. Kondo R, Monden Y. A questionaire about thymic epithelial tumors as compared to pulmonary atypical carcinoids. Nihon Kokyuki Geka Gakkai Zasshi 2001 ; 15 : 633-42.
69. Soga J, Yakuwa Y, Osaka M. Evaluation of 342 cases of mediastinal/thymic carcinoids collected from literature : a comparative study between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 1999 ; 5 : 285-92.
70. Kuo TT, Chang JP, Lin FJ, Wu WC, Chang CH. Thymic carcinomas : histopathological varieties and immunohistochemical study. Am J Surg Pathol 1990 ; 14 : 24-34.
71. Goto K, Kodama T, Matsuno Y, Yokose T, Asamura H, Kamiya N. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus. Mod Pathol 2001 ; 14 : 985-94.
72. Lauriola L, Erlandson RA, Rosai J. Neuroendocrine differentiation is a common feature of thymic carcinoma. Am J Surg Pathol 1998 ; 22 : 1059-66.
73. Oliveira AM, Tazelaar HD, Myers JL, Erickson LA, Llyod RV. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well- differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 2001 ; 25 : 815-9.
74. Kaufmann O, Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 2000 ; 36 : 415-20.